Why is this paracetamol maker bleeding?

The trusty paracetamol has remained the first line of defence against fever for over seven decades now. But it seems like Granules India , the leading paracetamol API manufacturer, is hit with a fever with no quick cure. In the last 12 months, its net profit has tanked 22 per cent YoY. Notably, its operating margin shrank to its lowest levels since FY18. Also, in the six months ending September 2023, its cash flow from operations contracted 91 per cent YoY! Operational disruptions affecting financials The company's profitability has taken a hit in the current financial year. TTM FY24 TTM FY23 Revenue (Rs cr) 4,526 4,346 PAT (Rs cr) 395 508 CFO (Rs cr)* 36 398 PAT margin (%) 8.7 11.7 TTM as of December 2024 and December 2023. *CFO (cash flow from operations) for six months as of September 2023 and September 2022.